Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Cancer Research
|
November 28, 2019
MEK Inhibitors in Lung Cancer-You Can Teach an Old Drug New Tricks
Jonathan J Havel
Genome Biology
|
April 9, 2015
High-resolution genomic analysis: the tumor-immune interface comes into focus
Jonathan J Havel, Timothy A Chan
Nature Reviews. Cancer
|
February 14, 2019
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J Havel, Diego Chowell, Timothy A Chan
International Immunology
|
April 7, 2016
The role of neoantigens in response to immune checkpoint blockade
Nadeem Riaz, Luc Morris, Jonathan J Havel, et al.
Cancer Immunology Research
|
December 22, 2017
ImmunoMap: A Bioinformatics Tool for T-cell Repertoire Analysis
John-William Sidhom, Catherine A Bessell, Jonathan J Havel, et al.
Molecular Cancer Research : MCR
|
March 6, 2021
Qa-1<sup>b</sup> Modulates Resistance to Anti-PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen Processing
Xiao Zhang, Erich Sabio, Chirag Krishna, et al.
Nature Genetics
|
September 27, 2016
Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy
Nadeem Riaz, Jonathan J Havel, Sviatoslav M Kendall, et al.
Journal of Molecular Cell Biology
|
November 19, 2015
Enabling systematic interrogation of protein-protein interactions in live cells with a versatile ultra-high-throughput biosensor platform
Xiu-Lei Mo, Yin Luo, Andrei A Ivanov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 4, 2008
Beta2-microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cells
Wen-Chin Huang, Jonathan J Havel, Haiyen E Zhau, et al.
JCI Insight
|
October 26, 2016
The head and neck cancer immune landscape and its immunotherapeutic implications
Rajarsi Mandal, Yasin Şenbabaoğlu, Alexis Desrichard, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Cancer Research
|
November 28, 2019
MEK Inhibitors in Lung Cancer-You Can Teach an Old Drug New Tricks
Jonathan J Havel
Genome Biology
|
April 9, 2015
High-resolution genomic analysis: the tumor-immune interface comes into focus
Jonathan J Havel, Timothy A Chan
Nature Reviews. Cancer
|
February 14, 2019
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J Havel, Diego Chowell, Timothy A Chan
International Immunology
|
April 7, 2016
The role of neoantigens in response to immune checkpoint blockade
Nadeem Riaz, Luc Morris, Jonathan J Havel, et al.
Cancer Immunology Research
|
December 22, 2017
ImmunoMap: A Bioinformatics Tool for T-cell Repertoire Analysis
John-William Sidhom, Catherine A Bessell, Jonathan J Havel, et al.
Molecular Cancer Research : MCR
|
March 6, 2021
Qa-1<sup>b</sup> Modulates Resistance to Anti-PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen Processing
Xiao Zhang, Erich Sabio, Chirag Krishna, et al.
Nature Genetics
|
September 27, 2016
Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy
Nadeem Riaz, Jonathan J Havel, Sviatoslav M Kendall, et al.
Journal of Molecular Cell Biology
|
November 19, 2015
Enabling systematic interrogation of protein-protein interactions in live cells with a versatile ultra-high-throughput biosensor platform
Xiu-Lei Mo, Yin Luo, Andrei A Ivanov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 4, 2008
Beta2-microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cells
Wen-Chin Huang, Jonathan J Havel, Haiyen E Zhau, et al.
JCI Insight
|
October 26, 2016
The head and neck cancer immune landscape and its immunotherapeutic implications
Rajarsi Mandal, Yasin Şenbabaoğlu, Alexis Desrichard, et al.
Page
of 2